Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression
Clinical trial NCT05304663 · WITHDRAWN
Trial details
- NCT number
- NCT05304663
- Sponsor
- Philogen S.p.A.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.